Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Bosch

Showing results (301-310 of 364) with videos related to

Pageof 37
Sort By:
Gastroenterology|September 27, 2020
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient DataOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
Ecology Letters|February 6, 2010
Factors driving pathogenicity vs. prevalence of amphibian panzootic chytridiomycosis in IberiaSusan F Walker, Jaime Bosch, Virgilio Gomez, et al.
Hepatology (Baltimore, Md.)|January 23, 2016
Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosisCarlos Noronha Ferreira, Susana Seijo, Aurelie Plessier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulationJuan Turnes, Juan Carlos García-Pagán, Monica González, et al.
Journal of Hepatology|September 4, 2012
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance studyJuan Carlos Garcia-Pagán, Marco Di Pascoli, Karel Caca, et al.
Gastroenterology|January 18, 2016
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With CirrhosisJuan G Abraldes, Candid Villanueva, Carles Aracil, et al.
Hepatology Communications|September 14, 2020
Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASHDavide Povero, Hirokazu Yamashita, Wenhua Ren, et al.
The New England Journal of Medicine|November 25, 2005
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosisRoberto J Groszmann, Guadalupe Garcia-Tsao, Jaime Bosch, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver diseaseSalvador Augustin, Mònica Pons, James B Maurice, et al.
Aging and Disease|August 24, 2019
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver DiseaseRaquel Maeso-Díaz, Martí Ortega-Ribera, Erica Lafoz, et al.
Pageof 37

Showing results (301-310 of 364) with videos related to

Sort By:
Pageof 37
Gastroenterology|September 27, 2020
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient DataOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
Ecology Letters|February 6, 2010
Factors driving pathogenicity vs. prevalence of amphibian panzootic chytridiomycosis in IberiaSusan F Walker, Jaime Bosch, Virgilio Gomez, et al.
Hepatology (Baltimore, Md.)|January 23, 2016
Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosisCarlos Noronha Ferreira, Susana Seijo, Aurelie Plessier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulationJuan Turnes, Juan Carlos García-Pagán, Monica González, et al.
Journal of Hepatology|September 4, 2012
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance studyJuan Carlos Garcia-Pagán, Marco Di Pascoli, Karel Caca, et al.
Gastroenterology|January 18, 2016
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With CirrhosisJuan G Abraldes, Candid Villanueva, Carles Aracil, et al.
Hepatology Communications|September 14, 2020
Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASHDavide Povero, Hirokazu Yamashita, Wenhua Ren, et al.
The New England Journal of Medicine|November 25, 2005
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosisRoberto J Groszmann, Guadalupe Garcia-Tsao, Jaime Bosch, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver diseaseSalvador Augustin, Mònica Pons, James B Maurice, et al.
Aging and Disease|August 24, 2019
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver DiseaseRaquel Maeso-Díaz, Martí Ortega-Ribera, Erica Lafoz, et al.
Pageof 37